TILRAY BRA. CL.2 DL-,0001TILRAY BRA. CL.2 DL-,0001TILRAY BRA. CL.2 DL-,0001

TILRAY BRA. CL.2 DL-,0001

No trades
See on Supercharts

TILRAY BRA. CL.2 DL-,0001 stock forum

TLRY past 5 days it’s up 420 percent lol gotta be a sign from the universe bro😂

TLRY Despite Tilray's current financial challenges, including cash burn and lack of profitability, the recent disclosure by Bryan Lanza regarding potential medical cannabis legalization could significantly benefit the company. Tilray's strong focus on medical cannabis products and its established presence in the market position it well to capitalize on any regulatory changes. The anticipated legalization could open up new revenue streams and improve market sentiment, potentially attracting investors and boosting stock performance. This development underscores Tilray's potential to emerge as a key player in the evolving cannabis industry.

Additionally, Donald Trump's recent promise to support medical cannabis legalization, combined with Bryan Lanza's close connection to him as a senior advisor, further strengthens the likelihood of favorable policy changes. This political backing could provide Tilray with a significant advantage in navigating the regulatory landscape and expanding its market presence.

Check out the new video that just came out on YouTube on Lanza's interview.

TLRY people are tax harvesting right now. it will go back to its normal levels in January

TLRY

…like every other ganja stonk they’ll rs 10:1 when it gets down to ~.30

TLRY this will never recover. it's -94% . pure trash

TLRY buy buy buy

TLRY ...loading the truck with 30,000 shrs goal ...here @ 52wk low

TLRY Tilray CFO Carl Merton's spouse recently purchased 26,000 shares of TLRY at $1.36 per share, signaling confidence in the company's future. Insider buying like this often aligns leadership interests with shareholders and reflects belief in the company's potential. A bullish sign for investors!

TLRY if it dips one more time, i'm loading up

TLRY is the 6th highest grossing craft beer distributor in the US. #1 in market share of cannabis in Canada and Germany. Institutional investment has been low but I think that tide should be shifting soon... As management seems to have effectively diversified.
Insiders (board members) are buying, directly and indirectly, debt to asset ratio leaves something to be desired but interesting nonetheless. Am I missing something? I'm open to info, especially to the contrary (please offer criticism - without worry of drama. I'm asking for a contradictory analysis - it keeps strategies honest).